Assessment of gene promoter hypermethylation for detection of cervical neoplasia
Open Access
- 30 May 2006
- journal article
- early detection-and-diagnosis
- Published by Wiley in International Journal of Cancer
- Vol. 119 (8) , 1908-1914
- https://doi.org/10.1002/ijc.22060
Abstract
Current cervical cancer screening is based on morphological assessment of Pap smears and associated with significant false negative and false positive results. Previously, we have shown that detection of hypermethylated genes in cervical scrapings using quantitative methylation‐specific PCR (QMSP) is a promising tool for identification of squamous cell cervical cancer. Aim of the present pilot‐study was to evaluate presence of hypermethylated genes in cervical carcinogenesis, both in squamous cell as well as adenocarcinomas. Cervical scrapings were obtained from 30 patients diagnosed with cervical cancer (20 squamous cell carcinomas and 10 adenocarcinomas) and 19 women with histologically normal cervices. The scraped cells were used for determination of promoter hypermethylation by QMSP for 12 genes and for morphological assessment. Overall, CALCA, DAPK, ESR1, TIMP3, APC and RAR‐β2 promoters were significantly more often hypermethylated in cancers than in controls, while adenocarcinomas were more often hypermethylated above the highest control ratio for APC, TIMP3 and RASSF1A promoters. Combining 4 genes (CALCA, DAPK, ESR1 and APC) yielded a sensitivity of 89% (with all adenocarcinomas identified), equal to cytomorphology (89%) and high‐risk human papilloma virus (Hr‐HPV; 90%). The 4‐gene QMSP proved theoretically superior to cytomorphology as well as Hr‐HPV in specificity (100% vs. 83 and 68%, respectively), because cytology identified 3 controls as moderate or severe dyskaryosis and 6 controls were positive for Hr‐HPV. In conclusions, QMSP of 4 gene promoters combined appears to have comparable sensitivity and potentially better specificity in comparison to “classic” cytomorphological assessment and Hr‐HPV detection. QMSP holds promise as a new diagnostic tool for both squamous cell carcinoma and adenocarcinoma of the cervix.Keywords
This publication has 38 references indexed in Scilit:
- Enhancement of human papilloma virus type 16 E7 specific T cell responses by local invasive procedures in patients with (pre)malignant cervical neoplasiaInternational Journal of Cancer, 2006
- Comparison of DNA hypermethylation patterns in different types of uterine cancer: Cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinomaInternational Journal of Cancer, 2005
- Detection of Hypermethylated Genes in Women with and Without Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 2005
- A Study of the Impact of Adding HPV Types to Cervical Cancer Screening and Triage TestsJNCI Journal of the National Cancer Institute, 2005
- DNA methylation profiling of cervical squamous intraepithelial lesions using liquid-based cytology specimensCancer, 2004
- QuantitativeRARβ2HypermethylationClinical Cancer Research, 2004
- The expression and tyrosine phosphorylation of E-cadherin/catenin adhesion complex, and focal adhesion kinase in invasive cervical carcinomasInternational Journal of Gynecologic Cancer, 2003
- The Rising Incidence of Adenocarcinoma Relative to Squamous Cell Carcinoma of the Uterine Cervix in the United States—A 24-Year Population-Based StudyGynecologic Oncology, 2000
- Human papillomavirus in malignant cervical lesions in Surinam, a high-risk country, compared to the Netherlands, a low-risk countryInternational Journal of Gynecologic Cancer, 1999
- Radical Hysterectomy for Stage IB1 vs IB2 Carcinoma of the Cervix: Does the New Staging System Predict Morbidity and Survival?Gynecologic Oncology, 1996